Assessment of dry-aged beef from commercial aging locations across the United States

Modern dry-aging is a culinary-inspired practice that involves storing meat at refrigerated temperatures without protective packaging. The dry-aging process has been observed to create unique flavors. The objective of the current study was to survey commercial dry-aging facility environments and observe palatability differences related to consumer acceptance. Seventy-two bone-in beef strip loins (Institutional Meat Purchase Specification #175) were acquired. Strip loins were randomly assigned to each of ten commercial dry-aging facilities. Additionally, a set of strip loins were wet-aged at the University of Idaho meat laboratory. Strip loins were shipped overnight to respective aging locations and dry-aged for 45-days then returned overnight to the University of Idaho meat laboratory. Strip loins were fabricated into steaks, vacuum packaged, and then frozen until further analyzed. Commercial dry-aging facility cooler conditions were observed to be different (P 0.05) among treatment-locations. Consumer taste panels indicated a difference (P < 0.01) in acceptability (6.27–7.24), tenderness (6.65–7.54), and flavor (5.58–6.79) based on aging treatment-location. Overall, the findings indicate that conditions within individual dry-aging facilities aid in producing unique dry-aged beef flavors.Funded by the Idaho Beef Council. We gratefully acknowledge Idaho Beef Council’s financial support (AG3963

Topical Application of Acerola Cherry Powder in Combination With Rosemary Extract Extends the Shelf Life of Beef Chuck Roll and Bone-In Short Rib Steaks

Improving the shelf life of steaks from beef chuck rolls and bone-in short ribs, items commonly exported, will increase the demand of beef in international markets. Our objectives were to determine the effect of topically applying combinations of acerola cherry powder and rosemary extract on steak color and lipid oxidation of beef chuck roll and bone-in short rib. USDA Choice beef chuck rolls (Institutional Meat Purchase Specifications [IMPS] 116A; N=9) andbone-in short ribs (IMPS 123A; N=18) were aged (0°C) 28 d and cut into 1.0 cm-thick steaks. Steak treatments included the following: untreated control (C) or topically sprayed (2 mL) with an acerola cherry powder solution (0.05% A), rosemary extract solution (0.10% R), or mixture of acerola cherry powder and rosemary extract (M1=0.05% A+0.1% R; M2=0.1% A+0.1% R; M3=0.05% A+0.2% R; M4=0.1% A+0.2% R). On day 0 of retail display, oxygen consumption, metmyoglobin-reducing activity, and lipid oxidation were measured. Lipid oxidation was evaluated again following 4 d of retail display. Chuck roll steak color was scored twice daily, whereas short rib lean and bone marrow color were scored once daily throughout 4 d of retail display. Treating chuck roll steaks with M2, M3, and M4 decreased lipid oxidation compared to C and A (P=0.004). In short rib steaks, lipid oxidation remained constant from day 0 to 4 treated with M4 but increased for all other treatments (P&lt;0.001). Chuck roll steaks treated with A, M2, and M3 were redder than C steaks (P=0.001). On days 0 and 4, untreated bone marrow was less red than all the antioxidant treated bone marrow (P=0.011). Antioxidant treatment did not improve subjective lean color for the chuck roll (P=0.324) or bone-in short rib (P=0.081). Topical application of M4 (0.1% acerola cherry powder and 0.2% rosemary extract) reduced lipid oxidation in both chuck roll and bone-in short rib steaks. Additionally, antioxidants alone or in combination with one another improve objective redness scores by up to 2 points; however, the subjective color panel did not observe lean color improvement

Extending the Shelf Life of Beef Steaks Using Acerola Cherry Powder and Rosemary Extract

Improvements in retail shelf life of exported beef will help with merchandising and increase competitiveness in the worldwide market for United States beef products. The objective of this study was to determine the effect of topically applying acerola cherry powder or rosemary extract from various suppliers on beef bone-in short rib steak and chuck roll steak shelf life. USDA Choice beef bone-in short ribs (IMPS 123A) and chuck rolls (IMPS 116A) were aged (0°C) for 28 d postfabrication. Following aging, 1.02-cm-thick steaks were cut (N = 126) and systematically assigned to a treatment based on steak location within the subprimal. Treatments included untreated control (C), topically sprayed (2 mL) with an acerola cherry powder solution (0.05%) from 1 of 3 suppliers (C1, C2, C3), or topically sprayed (2 mL) with a rosemary extract solution (0.10%) from 1 of 3 suppliers (R1, R2, R3). Half of the steaks were assigned to day 0 lipid oxidation, metmyoglobin-reducing activity (MRA), and oxygen consumption; the remaining steaks were assigned to color evaluation over 4 d of retail display followed by day 4 lipid oxidation and MRA. Short rib steaks treated with antioxidants had a brighter oxygenated lean color than control steaks (P &lt; 0.001). There was an interaction (P = 0.028) between time of retail display and MRA. Short rib steaks treated with C3 and R2 did not change in MRA between day 0 and 4 (P = 0.620, P = 0.428, respectively). Chuck roll steaks treated with C1, C2, C3, R2, and R3 all had a higher, or more desirable, MRA than the control steaks on day 0 (P &lt; 0.001). Applying topical antioxidants improves the shelf-life stability of steaks from beef bone-in short ribs and chuck rolls aged for an extended period

Beef Carcass Size and Aging Time Effects on Yield and Color Characteristics of Top Round Steaks

Variation in cut size and weight of fabricated subprimals is a challenge of increased beef carcass weights. Subsequently, variation in carcass size has resulted in consistency challenges during retail display. The objective of this study was to assess three aging periods of commercially available top rounds from varying carcass weights as it relates to yield and color characteristics. In the current study, 21 industry average weight (AW; 340 to 409 kg; no industry discount) beef carcasses and 21 oversized (OS; exceeding 454 kg; receive a discount) beef carcasses were evaluated. Carcasses were selected at a commercial beef packing plant, where the left and right (paired) top round subprimals of each carcass were procured. Paired top rounds were assigned to a short (8 d), average (23 d), or extended (42 d) postmortem aging period. After wet-aging, subprimals were fabricated into steaks for additional analysis. Steaks were evaluated as whole top round steaks or further fabricated into “ superficial ” and “ deep ” portions at 5.08 cm from the superficial edge of the Semimembranosus and the Adductor muscle. Top rounds and steaks from OS carcasses were larger (P &lt; 0.01) than those from AW carcasses. Quantitative color of the anatomically deep locations of the OS steaks had the greatest mean L* (lightness; P &lt; 0.01), a* (redness; P &lt; 0.01) and b* (yellowness; P &lt; 0.01) values. Extending the aging timeline increased L* (lightness; P &lt; 0.01), decreased a* (redness; P &lt; 0.01), and decreased b* (yellowness; P &lt; 0.01). Alternative top round steak fabrication that separates the deep and superficial anatomical locations could be an effective means of providing more uniform steaks

Telomerase promoter mutations in cancer: an emerging molecular biomarker?

João Vinagre, Vasco Pinto and Ricardo Celestino contributed equally to the manuscript.Cell immortalization has been considered for a long time as a classic hallmark of cancer cells. Besides telomerase reactivation, such immortalization could be due to telomere maintenance through the “alternative mechanism of telomere lengthening” (ALT) but the mechanisms underlying both forms of reactivation remained elusive. Mutations in the coding region of telomerase gene are very rare in the cancer setting, despite being associated with some degenerative diseases. Recently, mutations in telomerase (TERT) gene promoter were found in sporadic and familial melanoma and subsequently in several cancer models, notably in gliomas, thyroid cancer and bladder cancer. The importance of these findings has been reinforced by the association of TERT mutations in some cancer types with tumour aggressiveness and patient survival. In the first part of this review, we summarize the data on the biology of telomeres and telomerase, available methodological approaches and non-neoplastic diseases associated with telomere dysfunction. In the second part, we review the information on telomerase expression and genetic alterations in the most relevant types of cancer (skin, thyroid, bladder and central nervous system) on record, and discuss the value of telomerase as a new biomarker with impact on the prognosis and survival of the patients and as a putative therapeutic target